MyFinsight
Home
About
Contact
rxrx: the income statement
Download
Download image
Net loss
-$162,253K
(-69.29%↓ Y/Y)
Income tax benefit
(expense)
$3K
(-98.20%↓ Y/Y)
Loss before income
tax benefit
-$162,250K
(-69.58%↓ Y/Y)
Other income, net
$9,952K
(271.48%↑ Y/Y)
Grant
$192K
(0.00%↑ Y/Y)
License And Service
$4,983K
(-80.89%↓ Y/Y)
Loss from operations
-$172,202K
(-75.08%↓ Y/Y)
Total revenue
$5,175K
(-80.16%↓ Y/Y)
Total operating costs
and expenses
$177,377K
(42.54%↑ Y/Y)
General and
administrative
$41,628K
(10.25%↑ Y/Y)
Research and development
$121,062K
(62.28%↑ Y/Y)
Cost of revenue
$14,687K
(21.59%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)